Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Letting

4 Jul 2008 07:00

RNS Number : 3076Y
Derwent London PLC
04 July 2008
 



3PRESS RELEASE

4 July 2008

Derwent London plc ("Derwent London" / "Company")

DERWENT LONDON SECURES 20,000 SQ FT OFFICE PRE-LET 

AT 151 ROSEBERY AVENUEEC1

Derwent London plc is pleased to announce it has secured a 19,741 sq ft (1,834 sq m) pre-let at 151 Rosebery Avenue, EC1, its 25,000 sq ft (2,323 sq m) office refurbishment in Clerkenwell, to Momentum Activating Demand Ltd, ("Momentum"), part of the Interpublic Group.

Momentum has taken five floors (lower ground to third) at a rent of £732,000 per annum on a 15 year lease with a tenant-only break at the tenth year. The letting reflects £40 per sq ft on the best office space. The tenant has been given a 15 month rent free periodwith an additional three months if they do not exercise the break and a three month penalty if they do. Following the letting to Momentum, only the penthouse floor remains available comprising 4,538 sq ft (422 sq m).

Originally designed by Troughton McAslan in 1990, the building has been refurbished and modified by Hugh Broughton Architects, extending the ground floor, doubling the reception area and extensively landscaping the rear courtyard. The refurbishment works will be complete in September 2008. 

Simon Silver, Head of Development, Derwent London, comments: "This letting supports the investment we have made in refurbishing 151 Rosebery Avenue by attracting a global marketing agency. We are confident of letting up the remaining penthouse floor which features a barrel vaulted ceiling and great views. The completion of this project is further evidence of Derwent's skill in using its design led skills to attract occupiers who want to be located in London's vibrant villages and paying mid market rents."

Paul Biggins, CEO Momentum London, comments: "151 Roseberry Avenue is the ideal location and design for the Momentum London operation. As soon as we saw the property we knew we'd found a great home for the agency to support our future growth and development for years to come" 

- Ends -

For further information please contact:

 

Derwent London
John Burns
Tel: +44 (0)20 7659 3000
Financial Dynamics
Stephanie Highett / Dido Laurimore / Olivia Goodall
Tel: +44 (0)20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQXLFBVDBEBBX
Date   Source Headline
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.